• Tidak ada hasil yang ditemukan

table of contents

N/A
N/A
Protected

Academic year: 2024

Membagikan "table of contents"

Copied!
11
0
0

Teks penuh

(1)

Supplementary Appendix

This appendix has been provided by the authors to give readers additional information about their work.

Supplement to: Angel L, Amoroso N, Rafeq S, et al. Tracheostomy in COVID-19 Patients Requiring Mechanical Ventilation.

(2)

SUPPLEMENTARY APPENDIX TABLE OF CONTENTS

SUPPLEMENTARY TABLES AND FIGURES

Table 1s. Specialty position statements or communications evaluating the role of tracheostomy in critically ill patients with COVID-19

Page 2

Table 2s. Patient Characteristics, Interventions and Laboratory Results in Patients

with Early Tracheostomy, Late Tracheostomy and No Tracheostomy. Page 3

Table 3s and Figure 1s(a-b). Distribution of Aerosol Mass Concentration Reading for PDT during COVID-19, Trach Collar, and Patient Rooms Pre-Procedure

Page 6

Figure 2s. Balance summary of covariates for patients with Early Tracheostomy and No Tracheostomy before and after matching on propensity scores

Page 7

Figure 3s. Balance summary of covariates for patients with Early Tracheostomy and Late Tracheostomy before and after matching on propensity scores

Page 8

Figure 4s. Balance summary of covariates for patients with Early Tracheostomy and Not Early Tracheostomy (remaining orally intubated with never had a tracheostomy or had a tracheostomy after 13 days) before and after matching on propensity scores

Page 9

(3)

Table 1s. Specialty position statements or communications evaluating the role of tracheostomy in critically ill patients with COVID-19

Tracheostomy Guidelines for COVID 19 Patients and Scientific Organization

Reference Number American Association of Otolaryngology-Head and Neck Surgery 11 Canadian Society of Otolaryngology – Head & Neck Surgery 12

Literature review, Univ. California-Los Angeles, USA 13

Ear, Nose and Throat United Kingdom- ENTUK 14

American Association for the Surgery of Trauma 15

A global multidisciplinary Guidance 16

American College of CHEST physicians, American Association of Bronchoscopy and Interventional Pulmonary and the Association of Interventional Pulmonary Program Directors: Expert Panel Report; USA

17

(4)

Table 2s. Patient Characteristics, Interventions and Laboratory Results in Patients with Early Percutaneous Dilational (PDT) Tracheostomy, Late PDT and No Tracheostomy.

Variable

Early PDT (N=116)

Late PDT (n=89)

P value*

No Tracheostomy (n=189)

P value*

* Demographics and Medical History

Median age (IQR) – yrs. 59 (46-67) 64 (55-70) 0.01 67 (59-73) <0.001

Female Sex –― n (%) 23 (20%) 26 (29%) 61 (32%) 0.03

Ethnicity/Race – n (%) a

African American 8 (7%) 15 (17%) 0.05 34 (18%) 0.04

Hispanic 31 (27%) 15 (17%) 44 (23%)

White 46 (40%) 41 (46%) 74 (39%

Other 31 (27%) 18 (20%) 37 (20%)

Median Body-mass Index (IQR)b

<30 (n, %) 78 (67%) 61 (69%) 90 (48%)

≥30 (n, %) 38 (33%) 28 (31%) 99 (52%) 0.001

Comorbidities

Hyperlipidemia, Hypertension, Coronary

Disease, Heart Failure 61 (53%) 49 (55%) 93 (49%)

Diabetes 33 (28%) 31 (35%) 58 (31%)

Asthma/Chronic Obstructive Lung Disease 5 (4%) 0 12 (6%)

Chronic Kidney Disease 12 (1%) 11 (12%) 24 (13%)

Cerebrovascular Accident 15 (13%) 13 (15%) 19 (10%)

HIV 4 (3%) 0 3 (2%)

Smoking Status

Active or Previous Smoker 29 (25%) 19 (21%) 54 (29%)

Mechanical Ventilation and Oxygenation Values (median, IQR) Median Plateau Pressure (interquartile range)

– cm of H2O 25 (22, 29) 27 (24, 32) 0.008 27 (22, 32) 0.04

(5)

Median Peak Pressure (interquartile range) –

cm of H2O 29 (24, 32) 30 (25, 36) 31 (26, 33)

Median Positive End Expiratory Pressure

(PEEP) (interquartile range)- cm H2O 12 (10,15) 12 (10,15) 12 (10, 15) Positive End Expiratory Pressure (PEEP) (n,

%) 0.02

>12 cm H2O 53 (46%) 32 (36%) 86 (43%)

8-12 cm HO2 54 (47%) 52 (58%) 91 (48%)

<8 cm H2O 0 (8%) 5 (6%) 12 (6%)

Median PaO2/FiO2 ratio (IQR) 123 (81, 188) 90 (67, 154) 0.003 92 (71, 138) 0.001 PaO2/FiO2 ratio (n, %)

200 < PaO2/FIO2 ≤ 300; PEEP > 5 (n, %) 24 (21%) 11 (12%) 25 (13%) 100 < PaO2/FIO2 ≤ 200; PEEP >5 (n, %) 47 (41%) 27 (30%) 61 (32%) PaO2/FIO2 ≤ 100; PEEP > 5 (n, %) 45 (39%) 57 (51%) 103 (54%)

Median PaCO2 41 (35, 50) 37 (32, 53) 38 (32, 47) 0.06

≤ 40 56 (48%) 51 (57%) 107 (57%)

> 40 60 (52%) 38 (43%) 82 (43%)

Chest Radiograph (Start Mechanical Ventilation) Level 0-1: Normal or mild ground glass

infiltrated 2 (2%) 2 (2%) 8 (4%)

Level 2: Multilobar consolidations (2 or more

lobes, not ARDS pattern) 31 (27%) 17 (19%) 43 (23%)

Level 3: Multilobar consolidations with diffuse

distribution 82 (71%) 70 (79%) 137 (73%)

Berlin Definition of ARDS (Start of Mechanical Ventilation) Adult Respiratory Distress Syndrome (ARDS)

criteria by the Berlin Definition (n, %)

Mild (n, %) 12 (10%) 12 (13%) 15 (8%)

Moderate (n, %) 28 (24%) 18 (20%) 37 (20%)

Severe (n, %) 38 (33%) 39 (44%) 80 (43%)

Other 38 (33%) 20 (22%) 57 (30%)

(6)

Medications and Interventions Received while on Mechanical Ventilation

Deep sedation and paralysis (n, %) c 66 (57%) 52 (58%) 86 (46%)

High dose of Intravenous Steroids (n, %) d 72 (62%) 53 (60%) 101 (53%)

Hydroxychloroquine (n, %) 110 (95%) 86 (97%) 182 (96%)

Tocilizumab (ACTEMRA) 400 mg Intravenous

Infusion single dose (n, %) 60 (52%) 44 (49%) 71 (38%) 0.02

Prone Positioning (n %) e 72 (62%) 64 (72%) 146 (77%)

Anticoagulation f 85 (73%) 76 (85%) 136 (72%)

Extra corporeal membrane oxygenation

-ECMO (n, %) 36 (31%) 4 (4%) <0.001 5 (3%) <0.001

Dialysis (n, %) 26 (22%) 25 (28%) 68 (36%) 0.02

Baseline Labs and Inflammatory Markers (median value day 1-14 after initiation of mechanical ventilation) White Blood Cell Count (>12 10*3/ul) 57 (49%) 47 (53%) 104 (55%)

Lymphocyte Count (≤5%) 40 (34%) 38 (43%) 97 (51%) 0.006

Ferritin (>1500 ng/ml) 55 (47%) 42 (47%) 72 (39%)

C-Reactive Protein (>100mg/L) 36 (31%) 41 (46%) 0.04 112 (60%) <0.001

Median D dimer (>2500ng/ml) 50 (43%) 42 (47%) 74 (40%)

Percentages may not total 100 because of rounding. IQR denotes interquartile range, HIV human immunodeficiency virus, PaO2 partial pressure of arterial oxygen, FiO2 fraction inspirated oxygen, PaCO2 partial pressure of arterial carbon dioxide, cm of H2O centimeters of water, PTT partial thromboplastin time. P values not shown in the table were non-significant

*P-value for comparison of Early PDT group to Late PDT group using Wilcoxon Rank-sum test for continuous variables and Chi-square test for categorical variables

** P-value for comparison of Early PDT group to No Tracheostomy group using Wilcoxon Rank-sum test for continuous variables and Chi-square test for categorical variables

a Information in race and ethnic group was obtained from entries in medical records as reported by patients

b The body mass index is the weight in kilograms divided by the square of the height in meters.

c Defined as multiple sedatives and a paralytic infusion or paralytic boluses over 2 or more days

d Defined as a dose of IV steroids over 1-2 mg per Kg over 3 or more consecutive days

e Defined as prone positioning > 2 times over 2 or more days

(7)

f Full dose anticoagulation with therapeutic anti-Xa level>0.3IU/ml and/or PTT>45 sec

(8)

Table 3s and Figure 1s. Distribution of Aerosol Mass Concentration Reading for PDT during COVID-19, Trach Collar, and Patient Rooms Pre-Procedure

Procedure Type (n=total readings) Number of Patients

Exposure

Time (min) Median Total Aerosol Exposure (mg)

Median Aerosol

Concentration Reading (IQR) (mg/m3)

Maximum Aerosol Concentration Reading (mg/m3)

Mean Aerosol Concentration Reading (mg/m3)

COVID-19 Tracheostomy (n=7672) 15 8 0.49 0 (0-0.001) 2.2 0.003

Trach Collar (n=4500) 9 8 1.6 0.001 (0·001-0.004) 150 3.1

Room Pre-Procedure (n=2067) 15 4 0.35 0 (0-0.002) 0.71 0.003

We found that the median total aerosol exposure concentration readings (Figure 3S-a) and the distribution of aerosol reading for the new PDT procedure were significantly lower compared to the trach collar (p<·0001) and similar to the pre-procedure room readings. For the comparison of aerosol concentration readings between procedure types, the nonparametric Mood median test was used (α<0·05). Analyses were

performed using SAS, version 9·4 (SAS Institute, Cary NC).

Figure 1s-a. Figure 1s-b

(9)

Figure 2s. Balance summary of covariates for patients with Early Tracheostomy and No

Tracheostomy before and after matching on propensity scores with caliper 0.5. Standardized mean differences in the unmatched and matched sample (297 patients). All the p values in all the

variables used in the propensity score matched samples are non-significant.

(10)

Figure 3s. Balance summary of covariates for patients with Early Tracheostomy and Late Tracheostomy before and after matching on propensity scores. Standardized mean differences in the unmatched and matched sample (205 patients). All the p values in all the variables used in the propensity score matched samples are non-significant

(11)

Figure 4s. Balance summary of covariates for patients with Early Tracheostomy and Not Early Tracheostomy (Patients remained intubated that did not have a tracheostomy or later (>13 days) have a tracheostomy) before and after matching on propensity scores with caliper 0.5. Standardized mean differences in the unmatched and matched sample (386 patients). All the p values in all the variables used in the propensity score matched samples are non-significant

Referensi

Dokumen terkait

Analisis Data Hasil Belajar Kognitif Pre-test dan Tes 2 dengan Chi-Square Test pada SPSS 17.0.. Analisis Data Hasil Belajar Psikomotor Tes 1 dan Tes 2 dengan

Tabel 4.7 Ringkasan Hasil Wilcoxon Signed Ranks Test variabel ketepatan forehand drive pada p- Value ≤ 0,05 81 Tabel 4.8 Ringkasan Hasil hasil Wilcoxon signed ranks

Figure 3.1 The Illustration of Population and Sample ………57 Figure 3.2 The Illustration of Relationship Between the Variables ………...66 Figure 3.3 Process in Making Valid

Table 7: Friedmen Test Elements Mean Rank Chi Square Value P Value General Climate 2.05 .000 .023 OCTAPACE culture 1.18 HRD Mechanisms 2.14 Interpretation:- The above table shows

The results of the analysis of the relationship of free variables and bound variables using the chi- square test obtained a p-value of 0.018 with an OR of 3.04 which means that there is

Socio-demographic Test Statistic Correlation p-value Remarks Variables Coefficient Age Pearson’s r -.066 0.63 No significant relationship Sex Chi-square 0.29 0.86 No

Fit Statistics for Multinomial Probit Model Statistic Value Number of observations 141,851 Wald Chi-square p-value 55471.43 p... *Reference group is the combined Some Moderate

Contingency table for comparisons between diagnosis and degree of hearing loss using the Chi-square method and adjusting p value with the Bonferroni correction to compensate for